Studies have shown that EV-packaged CCR7-induced tumor cells recognizes and accumulates toward lymphogenic CCL19 and CCL21, thereby promoting preferential tumor cell localization in sentinel LNs1. The gene discussed is CCR7; the disease is neoplasm.